Abstract:Human milk alone has insufficient nutrients to meet preterm infant requirements and a multi-nutrient fortifier, bovine milk-based (BMBF) or human milk-based (HMBF), is recommended. As the nutrient composition of BMBF and HMBF differs [1, 2], the biochemical effects may also differ; these differences have not yet been reported. This secondary analysis of a randomized controlled trial comparing BMBF and HMBF examined the biochemical response to the different fortifiers in preterm infants which were hypothesized to differ given different intakes of protein and iron [3]. Infants born <1250 g who met eligibility criteria for the Optimizing Mothers' Milk for Preterm Infants (OptiMoM) trial (NCT02137473) were studied [3]. Following informed consent, infants were provided mother's milk first then pasteurized donor milk as required and had BMBF or HMBF added to human milk feeds in a blinded fashion depending on their randomization. The HMBF group received Prolact+4 and +6 (Prolacta Bioscience, City of Industry, USA) commencing at 100 mL/kg/day (81 kcal/dL, 2.2 g/dL protein, 0.1 mg/dL iron) and 140 mL/kg/day (88 kcal/dL, 2.7 g/dL protein, 0.2 mg/dL iron), respectively. In the BMBF group, 0.4 g/dL intact protein modular (Beneprotein, Nestle, Minneapolis, USA) was added to donor milk and Similac Human Milk Fortifier (Abbott Nutrition, Columbus, USA) 1:50 and 1:25 commenced at 100 mL/kg/day (72 kcal/dL, 1.7 g/dL protein, 0.2 mg/dL iron) and 140 mL/kg/day (78 kcal/dL, 2.2 g/dL protein, 0.4 mg/dL iron), respectively. Parenteral nutrition was discontinued at 120 mL/kg/day, enteral volumes increased 10-25 mL/kg/day, full feeds were considered 160 mL/kg/day, and energy increases were implemented if weight gain was <15 g/kg/day using Prolact+8 (95 kcal/dL) or Neosure (88 kcal/dL, Abbott Nutrition, Columbus, USA) in HMBF and BMBF groups, respectively. Both groups received multivitamin drops containing 375IU vitamin A, 200IU vitamin D and 17.5 mg vitamin C daily. Vitamin D 200IU was given daily until 2 kg. Each infant received 2-3 mg/kg/day elemental iron after full fortification. These doses were chosen bearing in mind the different micronutrient composition of the two diets while providing the same supplementation to both groups and thus maintaining blinding. The intervention lasted until 84 days of age, hospital discharge or establishment of oral feeds. The initial trial found no group differences in feeding tolerance or growth [3].

Glucose-regulatory hormones and growth in very preterm infants fed fortified human milk

COMMENTARY: Searching for biomarkers and regulators of growth in very preterm infants with new fortifiers

Mineral supplementation for very preterm infants fed fortified human milk

Biochemical response in preterm infants fed a human versus bovine milk-based fortifier

Systemic immune markers and infection risk in preterm infants fed human milk fortified with bovine colostrum or conventional fortifier, a secondary analysis of the FortiColos trial

Human milk derived fortifiers are associated with glucose, phosphorus, and calcium derangements

Human milk-derived versus bovine milk-derived fortifier use in very low birth weight infants: growth and vitamin D status

Human Milk Oligosaccharides, Growth, and Body Composition in Very Preterm Infants

Gestational Diabetes Mellitus Changes the Metabolomes of Human Colostrum, Transition Milk and Mature Milk.

Human Milk Fortification with Bovine Colostrum Is Superior to Formula‐Based Fortifiers to Prevent Gut Dysfunction, Necrotizing Enterocolitis, and Systemic Infection in Preterm Pigs

Effect of extended colostrum feeding on plasma glucagon-like peptide-1 concentration in newborn calves

The association of macronutrients in human milk with the growth of preterm infants

Preterm Birth and Human Milk Proteome: Are We Ready for Individualized Fortification?

The human milk endocannabinoidome and neonatal growth in gestational diabetes

Human milk nutrient fortifiers alter the developing gastrointestinal microbiota of very-low-birth-weight infants

The Effect of Maternal Milk on Tolerance and Growth in Premature Infants: A Hypothesis-generating Study

EGF and IgA in maternal milk, donor milk and milk fortifiers in the Neonatal Intensive Care Unit setting

Growth and Metabolic Responses in Low‐Birth‐Weight Infants Fed Human Milk Fortified with Human Milk Protein or with a Bovine Milk Protein Preparation

Human Milk Fortification in Very Preterm Infants in China: A Multicenter Survey

Comparison of Growth Outcomes Between Human Milk-Fed Preterm Infants on Standard Versus Adjustable Fortification Protocols

Insulin-Like Growth Factors (IGFs), IGF Binding Proteins, and Other Endocrine Factors in Milk: Role in the Newborn